Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 3 of the last 3 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 20 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
86 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Kliniek Development from Gent, company number BE0787649995, closed financial year 2025 with a result of € -91,632 after tax. For that financial year Kliniek Development recorded a gross margin of € -81,846 and equity of € -195,046. Compared with financial year 2024, the result moved from € -4,938 to € -91,632. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
€ -195,046
▼ € 91,632 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -91,632
▼ 1756 % more loss than in 2024
Profit after tax over the fiscal year.
€ 17,447
▲ 14% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -200,046.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
Debts at end 2025
€ 2.5 million
▲ 40% vs 2024
Loans from banks and other lenders, long and short.
€ 990,034
▲ € 877,132 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 80
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -102,828 | € -4,244 | € -81,846 | ▼ € 77,602 |
| Profit after taxes | € -103,476 | € -4,938 | € -91,632 | ▼ € 86,694 |
| Equity | € -98,476 | € -103,414 | € -195,046 | ▼ € 91,632 |
| Total debts | € 1,311,662 | € 1,905,944 | € 3,506,715 | ▲ 84% |
| Cash | € 20,899 | € 15,312 | € 17,447 | ▲ 14% |
| Retained profit | € -103,476 | € -108,414 | € -200,046 | ▼ € 91,632 |
| Bank debt | € 1,179,134 | € 1,792,979 | € 2,516,561 | ▲ 40% |
| Balance sheet total | € 1,213,186 | € 1,802,530 | € 3,311,669 | ▲ 84% |
Key figures of Kliniek Development, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Kliniek Development?
What happened at Kliniek Development in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 91,632. Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 103,476 loss in 2023 to € 91,632 loss in 2025.
A new publication or filing at Kliniek Development? We notify you, reason included.
Follow Kliniek DevelopmentDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of The Good Life Fund comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Kliniek DevelopmentBehind Kliniek Development is The Good Life Fund NV. The shares are held by The Good Life Fund (100%).
Directors
According to the 2025 annual accounts
Director · represented by Nicolas Bearelle
Also active at: Immostal, IMMOMENCH, Good Life Ekla, Good Life Holding, HEJME CB 105, Good Life PDV, GEGROND, Marie Thumas +3 more
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Nieuwewandeling 62
9000 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 86 companies are registered at this address.
All companies at this address →Good Life Canal
€ 647,891 gross margin · 2025
Immostal same network
€ -50,350 gross margin · 2025
SPORTTRADE INTERNATIONAL
ROEMMO INVEST
€ 522,908 gross margin · 2025
Revive World
€ 2.9 million revenue · 2025
+81 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Self-hosted
Hosting
SUCURI-SEC - Sucuri, US
Domain
Domain
rkd.ie
Registered
1997-06-26
Registrar
Blacknight Solutions
Expires
2035-06-27
Website info
Features
Security
Details
- Company number
- 0787.649.995
- VAT number
- BE 0787.649.995
- Registered office
- Nieuwewandeling 62, 9000 Gent
- Names & denominations
- Kliniek Development
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 June 2022
- Peppol
- Active · Active since 4 Dec 2025
- Contact
- rkd.ie
- Activities · NACE
Ontwikkeling van residentiële bouwprojecten